“嗑药减肥”席卷全球，股市大受震撼

华尔街见闻2023-10-15

“万能神药”效应下，诺和诺德和礼来或称为最大赢家，胰岛素、心瓣膜、食品制造商将被“干掉”？随着GLP-1类减肥药日益风靡，未来十年美国将有数百万人集体减掉数亿磅体重，在这个过程中数万亿美元的股市资金将重新洗牌。换句话说，股市正在被“减肥神药”颠覆。“万能神药”效应下，诺和诺德和同处于GLP-1类药物赛道的礼来或称为最大赢家，胰岛素、心瓣膜、食品等众多药企和其他制造商要小心了。减肥药独领股市风骚随着...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

至诚之道可以前知
2023-10-15
至诚之道可以前知
下周减肥药主场，开启狂飙模式！
- 至诚之道可以前知:
  减肥药板块里买最强的就行。
- 大米饭00:
  推荐几个股票，减肥相关的股票
- 奔跑吧美股:
  前期跌了那么多，现在反弹一下是正常的
- 黄老怪:
  减肥药赛道仅仅是短线的机会

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1194793217?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","is_english":false,"pubTime":"2023-10-15 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194793217","market":"us","top_or_hot":-1,"title":"“嗑药减肥”席卷全球，股市大受震撼","media":"华尔街见闻","content":"<div>\n<p>“万能神药”效应下，诺和诺德和礼来或称为最大赢家，胰岛素、心瓣膜、食品制造商将被“干掉”？随着GLP-1类减肥药日益风靡，未来十年美国将有数百万人集体减掉数亿磅体重，在这个过程中数万亿美元的股市资金将重新洗牌。换句话说，股市正在被“减肥神药”颠覆。“万能神药”效应下，诺和诺德和同处于GLP-1类药物赛道的礼来或称为最大赢家，胰岛素、心瓣膜、食品等众多药企和其他制造商要小心了。减肥药独领股市风骚随着...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3699627\">网页链接</a>\n\n</div>\n","source":"wallstreetcn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“嗑药减肥”席卷全球，股市大受震撼</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“嗑药减肥”席卷全球，股市大受震撼\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-15 11:38 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3699627><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>“万能神药”效应下，诺和诺德和礼来或称为最大赢家，胰岛素、心瓣膜、食品制造商将被“干掉”？随着GLP-1类减肥药日益风靡，未来十年美国将有数百万人集体减掉数亿磅体重，在这个过程中数万亿美元的股市资金将重新洗牌。换句话说，股市正在被“减肥神药”颠覆。“万能神药”效应下，诺和诺德和同处于GLP-1类药物赛道的礼来或称为最大赢家，胰岛素、心瓣膜、食品等众多药企和其他制造商要小心了。减肥药独领股市风骚随着...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3699627\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"https://wallstreetcn.com/articles/3699627","article_id":"1194793217","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":{"source":"wallstreetcn","url":"https://wallstreetcn.com/articles/3699627","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1194793217","pubTimestamp":1697341120,"columns":[],"sourceInfo":{"source_id":"wallstreetcn","name":"华尔街见闻"},"weMediaInfo":null,"summary":"“万能神药”效应下，诺和诺德和同处于GLP-1类药物赛道的礼来或称为最大赢家，胰岛素、心瓣膜、食品等众多药企和其他制造商要小心了。减肥药独领股市风骚随着GLP-1减肥药企业的影响力日益增强，它们已经成长为股市新的领头羊。毫无疑问，GLP-1将对这些赛道原有的企业造成冲击。与此同时，诺和诺德和礼来股价双双大涨。初步数据显示GLP-1类药物可使2型糖尿病患者病情缓解，生产胰岛素递送系统和糖尿病监测设备的公司股价也暴跌。","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NVO":"诺和诺德","LLY":"礼来"},"translate_title":"\"Taking drugs to lose weight\" swept the world and the stock market was greatly shocked","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/f3923bdadb1f687e21f8518046fc656a","symbols_score_info":{"LLY":1.1,"NVO":1.1},"content_text":"“万能神药”效应下，诺和诺德和礼来或称为最大赢家，胰岛素、心瓣膜、食品制造商将被“干掉”？随着GLP-1类减肥药日益风靡，未来十年美国将有数百万人集体减掉数亿磅体重，在这个过程中数万亿美元的股市资金将重新洗牌。换句话说，股市正在被“减肥神药”颠覆。“万能神药”效应下，诺和诺德和同处于GLP-1类药物赛道的礼来或称为最大赢家，胰岛素、心瓣膜、食品等众多药企和其他制造商要小心了。减肥药独领股市风骚随着GLP-1减肥药企业的影响力日益增强，它们已经成长为股市新的领头羊。手握Wegovy和Ozempic的诺和诺德，现在是欧洲最大的公司，市值高达4330亿美元，这家丹麦药企巨头的快速增长甚至直接影响了丹麦克朗的汇率和利率。与此同时，生产GLP-1类药物Mounjaro的礼来，现在已成为标普500指数第九大公司，市值5680亿美元。据金融服务集团古根海姆公司(Guggenheim Partners)高级管理董事Punit Mehta透露，这股减肥药热潮还可能在行业内引发更多整合，尤其是生物技术和制药公司。他本周二对媒体表示:我认为这最终将引发更多(并购)活动，我认为这个市场几乎正在我们眼前形成。这个市场有多大？据最新估计，2022年美国医疗支出总额达到4.4万亿美元。“万能神药”效应下，有人欢喜有人愁原本作为治疗糖尿病药物的GLP-1类药物不仅在减肥领域封神，对心脏病、肾病、痴呆、烟酒成瘾等问题也很能发挥有效作用，因此被外界奉为“万能神药”。毫无疑问，GLP-1将对这些赛道原有的企业造成冲击。例如，周二诺和诺德公布的一项药物试验结果表明，Semaglutide（司美格鲁肽，2型糖尿病药Ozempic和“减肥神药”Wegovy中的活性成分）可能对于治疗糖尿病患者肾衰竭有很大帮助。消息公布后，当天全球最大的肾脏透析提供商DaVita和Fresenius Medical Care双双重挫逾10%。与此同时，诺和诺德和礼来股价双双大涨。无创呼吸机制造商的股价在短短几个月内暴跌超过40%，因为有研究表明，减肥可以帮助减少睡眠呼吸暂停患者在睡眠时对无创呼吸机的依赖。初步数据显示GLP-1类药物可使2型糖尿病患者病情缓解，生产胰岛素递送系统和糖尿病监测设备的公司股价也暴跌。其中，连胰岛素泵巨头Tandem Diabetes Care和Insulet股价跌得最惨，今年以来累计跌幅分别达61%和54%。除此以外，药物试验数据显示GLP-1类药物可降低心脏病发作概率，这也拖累了心瓣膜相关设备制造商的股价。Ozempic效应还蔓延到食品饮料公司，因为数据表明GLP-1类药物通过使患者更快产生饱腹感，以帮助减肥。摩根士丹利对300名使用这些减肥药的患者的调查显示，他们的日摄入卡路里减少了20%至30%。零售巨头沃尔玛近日发出警告，称那些正在服用Ozempic、Wegovy和其他减肥药的消费者，购物需求有所降低。由此带来的负面情绪拖累沃尔玛、Costco等食品零售商以及可口可乐、百事可乐和麦当劳等食品公司的股价下跌。经济也将被Ozempic撼动？可以清楚看到，GLP-1类药物崛起对股市和经济将产生大量连锁反应。有分析认为，生产力可能会因此大幅提高，医疗保健行业可能会节省大量成本，甚至飞机运营商也可能因较轻的乘客带来燃油节省而变得更高效。高盛估计，到2035年肥胖症将使全球减少GDP4万亿美元，但如果足够多人开始服用这些药物，情况可能会改变。根据Trilliant Health的分析，截至2022年底，美国有900万人服用GLP-1类药物，并且这一数字有望飙升，美银美林估计，到2030年将有4800万美国人服用GLP-1类药物。GLP-1类药物的未来礼来的GLP-1类药物Mounjaro已获批用于2型糖尿病，但仍在等待美国食品药品监督管理局(FDA)批准将适应症扩展到肥胖，分析普遍认为该药物将成功获批。诺和诺德和礼来也正在开发GLP-1类药物（当前只能通过注射使用）的药丸，这可能会吸引那些害怕打针的患者。值得一提的是，保险可能是这些药物快速推广的最大催化剂。目前，如果不走保险，这些药物的费用可高达每月1000美元。虽然糖尿病患者的报销范围更广，但许多保险公司不愿报销这类减肥药。随着GLP-1类药物继续展示减肥以外的更多潜力，医疗保险公司可能会更倾向于开始为这些药物提供扩大的报销范围，大大降低患者的费用。高盛在8月表示:临床试验显示，这些药物可降低心脏病发作和卒中的风险。这些药物似乎也在通过对抗肥胖治疗心脏病，肥胖是导致死亡的主要原因。这表明，保险公司有必要重新考虑他们的做法。摩根大通预计，GLP-1类药物将成为有史以来最畅销的药物之一，到2030年的年销售额将达1000亿美元。如果这些销售估计准确，那么股市和经济将在短期和长期内感受到深远的影响。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":230760848666728,"gmtCreate":1697356715627,"gmtModify":1697356717138,"author":{"id":"3533639338107797","authorId":"3533639338107797","name":"至诚之道可以前知","avatar":"https://static.tigerbbs.com/aa00a1c09acbbf99518a8e2db4e74435","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3533639338107797","authorIdStr":"3533639338107797"},"htmlText":"下周减肥药主场，开启狂飙模式！","listText":"下周减肥药主场，开启狂飙模式！","text":"下周减肥药主场，开启狂飙模式！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/230760848666728","repostId":1194793217,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":8077224,"gmtCreate":1697372148157,"gmtModify":1697372151957,"authorId":3533639338107797,"author":{"id":3533639338107797,"idStr":"3533639338107797","authorId":3533639338107797,"name":"至诚之道可以前知","avatar":"https://static.tigerbbs.com/aa00a1c09acbbf99518a8e2db4e74435","vip":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.06","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":230760848666728,"type":1,"supId":230791133335792,"prevId":0,"content":"减肥药板块里买最强的就行。","text":"减肥药板块里买最强的就行。","html":"减肥药板块里买最强的就行。"},{"id":230791133335792,"gmtCreate":1697367844577,"gmtModify":1697367848198,"authorId":3479274821093442,"author":{"id":3479274821093442,"idStr":"3479274821093442","authorId":3479274821093442,"name":"大米饭00","avatar":"https://static.tigerbbs.com/a5f5f4f89479e297edd3c368512cf6da","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":230760848666728,"type":1,"supId":0,"prevId":0,"content":"<p>推荐几个股票，减肥相关的股票</p>","text":"<p>推荐几个股票，减肥相关的股票</p>","html":"<p>推荐几个股票，减肥相关的股票</p>"},{"id":230790509748296,"gmtCreate":1697367820477,"gmtModify":1697367824126,"authorId":3479274709946712,"author":{"id":3479274709946712,"idStr":"3479274709946712","authorId":3479274709946712,"name":"奔跑吧美股","avatar":"https://static.tigerbbs.com/190c480144551a8d6ba305539b5ededa","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":230760848666728,"type":1,"supId":0,"prevId":0,"content":"<p>前期跌了那么多，现在反弹一下是正常的</p>","text":"<p>前期跌了那么多，现在反弹一下是正常的</p>","html":"<p>前期跌了那么多，现在反弹一下是正常的</p>"},{"id":230790406004808,"gmtCreate":1697367795149,"gmtModify":1697367799009,"authorId":3479274732372511,"author":{"id":3479274732372511,"idStr":"3479274732372511","authorId":3479274732372511,"name":"黄老怪","avatar":"https://static.tigerbbs.com/8d01265730fbb9a0b9e195d51c4c1680","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":230760848666728,"type":1,"supId":0,"prevId":0,"content":"<p>减肥药赛道仅仅是短线的机会</p>","text":"<p>减肥药赛道仅仅是短线的机会</p>","html":"<p>减肥药赛道仅仅是短线的机会</p>"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":13,"commentSize":1,"repostSize":2,"favoriteSize":22,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194793217"}